|
Prescription Drug Search
Strengths available for Bezafibrate :
Strengths available for Bezafibrate SR:
Browse Alphabetically:
A
·
B
·
C
·
D
·
E
·
F
·
G
·
H
·
I
·
J
·
K
·
L
·
M
·
N
O
·
P
·
Q
·
R
·
S
·
T
·
U
·
V
·
W
·
X
·
Y
·
Z
·
#
Information about MyGlobalPharmacy.com
List of countries where we can ship Bezafibrate:
- Albania
- Antigua and Barbuda
- Azerbaijan
- Belarus
- Belize
- Bolivia
- Bosnia and Herzegovina
- China
- Colombia
- Costa Rica
- Cuba
- Czech Republic
- Dominican Republic
- Ecuador
- Egypt
- El Salvador
- Georgia
- Gibraltar
- Guatemala
- Honduras
- India
- Iran
- Jamaica
- Jordan
- Luxembourg
- Mauritius
- Morocco
- New Zealand
- Panama
- Romania
- Russian Federation
- Saudi Arabia
- Seychelles
- Slovakia
- Spain
- Taiwan
- Ukraine
- United Kingdom, UK
- United States, US
- Uruguay
Latest news releases on Bezafibrate:
Effects of Bezafibrate on Lipid and Glucose Metabolism in Dyslipidemic Patients With Diabetes - Medscape News
Background The hypoglycemic effect of bezafibrate is well established, but administration to a large population of patients with diabetes has not been reported. We investigated glycemic control, relationship between lipid metabolism and HbA1c ...
LDL Lowering in Peripheral Arterial Disease: Role of Treating HDLs & Triglycerides in PAD - Medscape News
[51] In a multicenter, placebo-controlled trial of a fibrate (bezafibrate) in patients with known lower extremity PAD there was a rise in HDL concentration and lowering of triglycerides in the treatment group with fewer nonfatal coronary events and reduced ...
Stellar Pharmaceuticals Inc. Secures US$6.0 Million Term Loan to Support Market Growth - Market Wire
Stellar markets Bezalip® SR (bezafibrate), Soriatane® (acitretin), NeoVisc® (1.0% sodium hyaluronate solution) and Uracyst® (sodium chondroitin sulfate solution 2%) in the Canadian market. Additionally, NeoVisc® and Uracyst® are commercially ...
Stellar Pharmaceuticals Reports First Quarter 2012 Financial Results - Market Wire
Stellar markets Bezalip® SR (bezafibrate), Soriatane® (acitretin), NeoVisc® (1.0% sodium hyaluronate solution) and Uracyst® (sodium chondroitin sulfate solution 2%) in the Canadian market. Additionally, NeoVisc® and Uracyst® are commercially ...
